NCT02940249

Brief Summary

Postprandial hyperglycaemia can lead to adverse modifications to functional proteins within the body and eventually lead to the development of type 2 diabetes. Previous research by this group has shown that an apple polyphenol extract reduced hyperglycaemia following a high-carbohydrate meal. The aim of this study is to investigate the effects of lower doses of the apple extract on postprandial glycaemia, insulinaemia and plasma gastric inhibitory polypeptide concentrations following a mixed carbohydrate test meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 20, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

June 17, 2020

Completed
Last Updated

June 17, 2020

Status Verified

March 1, 2018

Enrollment Period

10 months

First QC Date

October 19, 2016

Results QC Date

January 24, 2020

Last Update Submit

June 2, 2020

Conditions

Keywords

PolyphenolAppleFruitHyperglycaemiaMetabolic

Outcome Measures

Primary Outcomes (1)

  • Postprandial Glycaemia

    Primary outcome: Area over baseline t+0-30 min for plasma glucose

    30 min following the test drink

Secondary Outcomes (13)

  • Postprandial Insulinaemia

    baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink

  • Postprandial Glucose-dependent Insulinotropic Polypeptide (GIP) Concentrations

    baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink

  • Postprandial Glucagon-like Peptide-1 (GLP-1) Concentrations

    baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink

  • Postprandial C-peptide Concentrations

    baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink

  • Postprandial Non-esterified Fatty Acid (NEFA) Concentrations

    baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink

  • +8 more secondary outcomes

Other Outcomes (2)

  • 7-day Food Diary

    Baseline

  • Women's Health Questionnaire

    Baseline

Study Arms (4)

1.2 g apple polyphenols

EXPERIMENTAL

1200 mg apple polyphenols delivered in a low sugar drink.

Dietary Supplement: Apple polyphenols

0.9 g apple polyphenols

EXPERIMENTAL

900 mg apple polyphenols delivered in a low sugar drink.

Dietary Supplement: Apple polyphenols

0.6 g apple polyphenols

EXPERIMENTAL

600 mg apple polyphenols delivered in a low sugar drink.

Dietary Supplement: Apple polyphenols

Placebo

PLACEBO COMPARATOR

No polyphenols delivered in a low sugar drink.

Dietary Supplement: Placebo

Interventions

Apple polyphenolsDIETARY_SUPPLEMENT

Drinks will be delivered in random order at 4 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.

0.6 g apple polyphenols0.9 g apple polyphenols1.2 g apple polyphenols
PlaceboDIETARY_SUPPLEMENT
Placebo

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-70 y
  • Male and female

You may not qualify if:

  • Body Mass Index 18-35 kg/m2
  • Able to understand the information sheet and willing to comply with study protocol
  • Able to give informed written consent
  • Those diagnosed with Phenylketonuria (PKU)
  • Those with known or suspected food and/or paracetamol intolerances, allergies or hypersensitivity
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study
  • Women who are breast feeding
  • Participation in another clinical trial
  • Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.
  • Full Blood Counts and Liver Function test results outside of the normal range.
  • Current smokers, or reported giving up smoking within the last 6 months
  • History of substance abuse or alcoholism
  • Reported history of Cardiovascular disease, diabetes (or fasting glucose ≥ 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function
  • Unwilling to restrict consumption of specified high polyphenol foods for 48 h before the study
  • Weight change \>3kg in preceding 2 months and body mass index \<18 or \>35 kg/m2
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Metabolic Research Unit at King's College London

Waterloo Campus, London, SE1 9NH, United Kingdom

Location

MeSH Terms

Conditions

Hyperglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Results Point of Contact

Title
Dr Wendy Hall
Organization
King's College London

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2016

First Posted

October 20, 2016

Study Start

January 1, 2017

Primary Completion

November 1, 2017

Study Completion

February 1, 2018

Last Updated

June 17, 2020

Results First Posted

June 17, 2020

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations